newsfilter
← Latest News
GlobeNewswire·

Neos Therapeutics Announces Issuance of New U.S. Methods of Use Patent for N-desethyloxybutynin

DALLAS and FORT WORTH, Texas, April 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous...